Showing results (121-130 of 132) with videos related to
Sort By:
Pageof 14
Journal of Medical Virology|November 1, 1994
Genotyping of hepatitis C virus isolates by a modified polymerase chain reaction assay using type specific primers: epidemiological applicationsA Widell, S Shev, S Månsson, et al.Clinical Immunology and Immunopathology|March 1, 1984
Virologic, immunologic, and clinical observations on a patient during the incubation, acute, and convalescent phases of infectious mononucleosisE Svedmyr, I Ernberg, J Seeley, et al.Vox Sanguinis|January 1, 1993
Second-generation hepatitis C Elisa antibody tests confirmed by the four-antigen recombinant immunoblot assay correlate well with hepatitis C viremia and chronic liver disease in Swedish blood donorsS Shev, U Foberg, A Fryden, et al.Journal of Virological Methods|December 1, 1991
IgM-antibody response to hepatitis C virus antigens in acute and chronic post-transfusion non-A, non-B hepatitisK H Chau, G J Dawson, I K Mushahwar, et al.Journal of Hepatology|May 1, 1997
Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centersS W Schalm, B E Hansen, L Chemello, et al.Gut|August 18, 2005
Relation between viral fitness and immune escape within the hepatitis C virus proteaseJ Söderholm, G Ahlén, A Kaul, et al.Gut|September 14, 2004
Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapyB J Veldt, G Saracco, N Boyer, et al.Journal of Viral Hepatitis|March 16, 2013
Dynamic tailoring of treatment durations improves efficiency of hepatitis C treatment with pegylated interferon and ribavirinM Lindh, B Arnholm, P Björkman, et al.Scandinavian Journal of Gastroenterology|June 1, 1996
Factors influencing the response to interferon therapy in chronic hepatitis C. Studies on viral genotype and induction of 2',5'-oligoadenylate synthetase in the liver and peripheral blood cellsD Grandér, R Hultcrantz, O Weiland, et al.Gastroenterology|July 27, 1999
Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: analysis of individual patient data of six controlled trials. Eurohep Study Group for Viral HepatitisS W Schalm, O Weiland, B E Hansen, et al.Pageof 14